Moderna Pauses mRNA RSV Vaccine Trial For Children

Health & LifestyleNewsPublisher's Picks
498

Listen to article (english)

Translate to Spanish or other 102 languages!

In recent clinical trials, two experimental RSV vaccines for babies may not only have failed to protect them, but actually made some of them sicker when they got RSV or another respiratory virus. Image for illustration purposes
In recent clinical trials, two experimental RSV vaccines for babies may not only have failed to protect them, but actually made some of them sicker when they got RSV or another respiratory virus. Image for illustration purposes

Mega Doctor News

- Advertisement -

By Jon Cohen / Science.org

Recently approved adult vaccines against respiratory syncytial virus (RSV) are already saving lives. But prospects have dimmed for some infant vaccines against the virus, which each year kills up to 100,000 children under age 5 around the world and is the leading cause of infant hospitalizations in the United States. In recent clinical trials, two experimental RSV vaccines for babies may not only have failed to protect them, but actually made some of them sicker when they got RSV or another respiratory virus. 

Follow the link below for the full story:

- Advertisement -

https://www.science.org/content/article/safety-signal-moderna-s-rsv-vaccine-studies-halts-trials-other-vaccines-childhood

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Stay-At-Home Mom Turns Her Life Around At STC 
Next article
Help Loved Ones Seek Support, Medical Help Early for Holiday Anxiety, Depression

More Articles

TMA Honors Georgetown Pediatrician for a Career of Distinguished Service 

The Texas Medical Association (TMA) has honored Georgetown pediatrician John W. Hellerstedt, MD, with the 2026 TMA Distinguished Service Award in recognition of his 45 years of exemplary service to patients, public health, and organized medicine.   

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.

STC opens Wellness Center at Health Science Professions Campus

South Texas College recently inaugurated a new Wellness Center at its Health Science Professions Campus in McAllen, giving students, faculty and staff free access to a space designed to support both physical and mental well-being.
- Advertisement -